Literature DB >> 16098053

Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo.

Asem Alkhateeb, Pamela R Fain, Richard A Spritz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16098053     DOI： 10.1111/j.0022-202X.2005.23822.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  22 in total

1.  Tfap2a and Foxd3 regulate early steps in the development of the neural crest progenitor population.

Authors:  Wen-Der Wang; David B Melville; Mercedes Montero-Balaguer; Antonis K Hatzopoulos; Ela W Knapik
Journal:  Dev Biol       Date:  2011-09-22       Impact factor: 3.582

Review 2.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

3.  FoxD3 regulation of Nodal in the Spemann organizer is essential for Xenopus dorsal mesoderm development.

Authors:  Aaron B Steiner; Mark J Engleka; Qun Lu; Eileen C Piwarzyk; Sergey Yaklichkin; Julie L Lefebvre; James W Walters; Liliam Pineda-Salgado; Patricia A Labosky; Daniel S Kessler
Journal:  Development       Date:  2006-11-08       Impact factor: 6.868

Review 4.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

Authors:  Hervé Acloque; Meghan S Adams; Katherine Fishwick; Marianne Bronner-Fraser; M Angela Nieto
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

5.  FOXD3/FOXD4 is required for the development of hindgut in the rat model of anorectal malformation.

Authors:  Luo-Jia Wang; Wei-Lin Wang; Hong Gao; Yu-Zuo Bai; Shu-Cheng Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

Review 6.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

7.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

Review 8.  The genetic architecture of vitiligo.

Authors:  Genevieve H L Roberts; Stephanie A Santorico; Richard A Spritz
Journal:  Pigment Cell Melanoma Res       Date:  2019-12-04       Impact factor: 4.693

9.  Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.

Authors:  Giuseppe Matarese; Claudia La Rocca; Hyun-Seuk Moon; Joo Young Huh; Mary T Brinkoetter; Sharon Chou; Francesco Perna; Dario Greco; Holly P Kilim; Chuanyun Gao; Kalliope Arampatzi; Zhaoxi Wang; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.

Authors:  Yunqing Ren; Sen Yang; Shengxin Xu; Min Gao; Wei Huang; Tianwen Gao; Qiaoyun Fang; Cheng Quan; Chi Zhang; Liangdan Sun; Yanhua Liang; Jianwen Han; Zhimin Wang; Fengyu Zhang; Youwen Zhou; Jianjun Liu; Xuejun Zhang
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.